GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daewon Pharmaceutical Co Ltd (XKRX:003220) » Definitions » Shiller PE Ratio

Daewon Pharmaceutical Co (XKRX:003220) Shiller PE Ratio : 13.81 (As of May. 15, 2025)


View and export this data going back to 1999. Start your Free Trial

What is Daewon Pharmaceutical Co Shiller PE Ratio?

As of today (2025-05-15), Daewon Pharmaceutical Co's current share price is ₩13830.00. Daewon Pharmaceutical Co's E10 for the quarter that ended in Dec. 2024 was ₩1,001.65. Daewon Pharmaceutical Co's Shiller PE Ratio for today is 13.81.

The historical rank and industry rank for Daewon Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

XKRX:003220' s Shiller PE Ratio Range Over the Past 10 Years
Min: 12.74   Med: 20.64   Max: 32.93
Current: 13.67

During the past years, Daewon Pharmaceutical Co's highest Shiller PE Ratio was 32.93. The lowest was 12.74. And the median was 20.64.

XKRX:003220's Shiller PE Ratio is ranked better than
79.24% of 525 companies
in the Drug Manufacturers industry
Industry Median: 24.6 vs XKRX:003220: 13.67

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Daewon Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2024 was ₩16.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₩1,001.65 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Daewon Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Daewon Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daewon Pharmaceutical Co Shiller PE Ratio Chart

Daewon Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.30 20.85 20.44 15.77 14.23

Daewon Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.77 14.39 13.88 14.30 14.23

Competitive Comparison of Daewon Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Daewon Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daewon Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daewon Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Daewon Pharmaceutical Co's Shiller PE Ratio falls into.


;
;

Daewon Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Daewon Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=13830.00/1001.65
=13.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daewon Pharmaceutical Co's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Daewon Pharmaceutical Co's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=16/121.1352*121.1352
=16.000

Current CPI (Dec. 2024) = 121.1352.

Daewon Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 169.783 99.721 206.243
201506 239.418 100.051 289.873
201509 136.140 100.111 164.731
201512 251.154 100.220 303.567
201603 170.847 100.561 205.802
201606 199.859 100.791 240.200
201609 315.907 101.461 377.163
201612 232.900 101.561 277.787
201703 146.091 102.851 172.063
201706 -97.947 102.611 -115.629
201709 385.978 103.491 451.786
201712 38.183 102.991 44.910
201803 305.047 104.101 354.963
201806 243.166 104.130 282.876
201809 231.836 105.651 265.815
201812 288.488 104.351 334.890
201903 262.131 104.491 303.886
201906 287.267 104.881 331.787
201909 290.858 105.200 334.915
201912 387.811 105.121 446.889
202003 344.891 105.354 396.552
202006 199.723 105.112 230.169
202009 156.264 106.198 178.244
202012 98.937 105.765 113.314
202103 -369.903 107.357 -417.376
202106 139.806 107.579 157.424
202109 295.146 108.759 328.731
202112 262.136 109.676 289.524
202203 483.000 111.848 523.105
202206 342.000 114.072 363.175
202209 510.000 114.715 538.542
202212 144.000 115.179 151.446
202303 459.000 116.507 477.232
202306 374.000 117.182 386.617
202309 252.000 118.964 256.600
202312 35.000 118.837 35.677
202403 436.000 120.123 439.673
202406 -36.000 120.007 -36.338
202409 313.000 120.861 313.710
202412 16.000 121.135 16.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Daewon Pharmaceutical Co  (XKRX:003220) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Daewon Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Daewon Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Daewon Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
229-3 Yongdap-dong, Seongdong-gu, Seoul, KOR, 133-850
Daewon Pharmaceutical Co Ltd is active in the healthcare sector in Korea. Its main business involves antipyretics, respiratory drugs, cardiovascular drugs, and neuromuscular drugs. It also produces a range of health foods such as multivitamins. The company operates on a global basis.

Daewon Pharmaceutical Co Headlines

No Headlines